• Disclaimer
• SiteMap
• Home

• about us
  • Corporate Profile
  • Executive Management
  • Board of Directors
• technology
  • GIPET®
  • Facility
  • Strategic Partnering
• portfolio
  • Product Pipeline
  • Strategic Partnering
  • Orazol™ (Breast Cancer)
  • Orazol™ (Bone Metastases)
  • Almerol™ (MER-103)
  • Acyline (MER-104)
  • MER-102
• investor relations
  • Corporate Profile
  • Share Information
  • Presentations
  • Annual Reports /
    Financial Information
  • Financial Calendar
  • Investor Alert
  • Regulatory News
  • Corporate Governance
  • Analyst Coverage
  • Advisors and Registrars
  • Ownership Summary
  • Rule 26 Information
• media
  • Press Releases / Publications
  • Events
  • Gallery
• contact
  • Contact Details
  • Careers

Presentations

• Print page
• Email page

2011

March	Merrion Pharmaceuticals Plc Investor Relations Presentation

2010

02 June	Merrion Pharmaceuticals Presentation at UBS Global Life Sciences Conference London
05 May	Merrion Pharmaceuticals Presentation at Bio Chicago 2010
08 March	Financial Results Presentation

2009

29 Oct	Merrion Pharmaceuticals Investor Presentation at the Official Opening Ceremony of their new Citywest Facility
21 Sep	Jonathan O'Connell, CFO, Presentation at UBS Global Life Science Conference, New York
18 Feb	Merrion CEO, John Lynch, Addresses Biobusiness Conference, Geneva, Switzerland.